Related Experiment Video
Updated: May 7, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Periconceptional use of opioids and the risk of neural tube defects
Mahsa M Yazdy1, Allen A Mitchell, Sarah C Tinker
1Slone Epidemiology Center at Boston University, Boston, Massachusetts; and the National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Insights
Maternal opioid use during early pregnancy is linked to a higher risk of neural tube defects in newborns. This study suggests a modest increase in birth defect prevalence associated with periconceptional opioid exposure.
Area of Science:
- Obstetrics and Gynecology
- Pediatric Neurology
- Pharmacology
Background:
- Opioid analgesics are effective for pain management but their impact on developing fetuses is not fully understood.
- The periconceptional period is a critical window for organogenesis, making it sensitive to environmental exposures.
- Neural tube defects (NTDs) are serious congenital anomalies with significant public health implications.
Purpose of the Study:
- To investigate the association between maternal opioid use in the periconceptional period and the risk of neural tube defects in offspring.
- To quantify the potential increased risk of NTDs following opioid exposure during early pregnancy.
Main Methods:
- A case-control study utilizing data from the Slone Epidemiology Center Birth Defects Study (1998-2010).
- Mothers of 305 infants with NTDs were compared to mothers of 7,125 non-malformed controls and 13,405 malformed controls.
- Logistic regression models were employed to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for periconceptional opioid use.
Main Results:
- Mothers reporting opioid use in the periconceptional period had a higher incidence of NTDs compared to both non-malformed (OR 2.2) and malformed (OR 1.9) control groups.
- The association remained significant when offspring were restricted to those with spina bifida (ORs 2.5 and 2.2, respectively).
- Periconceptional opioid use was reported by 3.9% of mothers with NTD offspring versus 1.6% and 2.0% in control groups.
Conclusions:
- Maternal opioid use during the periconceptional period is associated with a modest increased risk of neural tube defects.
- This association suggests that approximately 5.9 per 10,000 live births may be attributed to NTDs among women using opioids.
- The findings highlight the importance of considering medication safety during early pregnancy.
Objective:
Opioid medications are among the most effective analgesics. However, the consequences of opioid exposure to the developing human offspring are not known. We assessed whether maternal opioid use in the periconceptional period was associated with the risk of neural tube defects in the offspring.
Methods:
We used data from 1998 to 2010 from the Slone Epidemiology Center Birth Defects Study, an ongoing case-control study. Mothers were interviewed by telephone within 6 months of delivery about sociodemographic factors and exposures during pregnancy including detailed questions on type and timing of medication use. Mothers of 305 offsprings with neural tube defect were compared with mothers of 7,125 offsprings in the nonmalformed control group and 13,405 offsprings in the malformed control group. Periconceptional opioid use was defined as any reported use in the 2 months after the last menstrual period. Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) adjusted for study center.
Results:
A higher percentage of mothers of offsprings with neural tube defects (3.9%) reported using an opioid medication than mothers of offsprings in the nonmalformed control group (1.6%) and offsprings in the malformed control group (2.0%) with adjusted ORs of 2.2 (95% CI 1.2 -4.2) and 1.9 (95% CI 1.0 -3.4), respectively. When offsprings were restricted to those with spina bifida, the adjusted ORs were 2.5 (95% CI 1.3-5.0) and 2.2 (95% CI 1.1-4.1), respectively.
Conclusion:
A 2.2-fold increase in risk would translate to a neural tube defect prevalence of 5.9 per 10,000 live births among women who use opioids. Overall, opioid use in the periconceptional period appeared to be associated with a modest increased risk of neural tube defects.
Level Of Evidence:
: II.
Related Concept Videos
Teratogenicity
Opioid Analgesics: Morphine and Other Natural Cogeners
Neurulation
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
